Co-Target(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T98271 | Target Info | |||
| Target Name | HUMAN adaptor-associated kinase 1 (AAK1) | ||||
| Synonyms |
Adaptor-associated kinase 1
Click to Show/Hide
|
||||
| Gene Name | AAK1 | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Co-Targets of This Target | Top | |||||
|---|---|---|---|---|---|---|
| Co-Target Name | Janus kinase 2 (JAK-2) | Successful Target | ||||
| UniProt ID | JAK2_HUMAN | |||||
| Gene Name | JAK2 | |||||
| Synonyms |
Tyrosine-protein kinase JAK2
Click to Show/Hide
|
|||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 0.8 nM | [1] | ||
| Co-Target Name | Janus kinase 1 (JAK-1) | Successful Target | ||||
| UniProt ID | JAK1_HUMAN | |||||
| Gene Name | JAK1 | |||||
| Synonyms |
Tyrosine-protein kinase JAK1; JAK1B; JAK1A
Click to Show/Hide
|
|||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 0.99 nM | [1] | ||
| Co-Target Name | Janus kinase 3 (JAK-3) | Successful Target | ||||
| UniProt ID | JAK3_HUMAN | |||||
| Gene Name | JAK3 | |||||
| Synonyms |
Tyrosine-protein kinase JAK3; Leukocyte janus kinase; L-JAK
Click to Show/Hide
|
|||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 25 nM | [1] | ||
| Co-Target Name | TYK2 tyrosine kinase (TYK2) | Successful Target | ||||
| UniProt ID | TYK2_HUMAN | |||||
| Gene Name | TYK2 | |||||
| Synonyms |
Non-receptor tyrosine-protein kinase TYK2
Click to Show/Hide
|
|||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 8.7 nM | [1] | ||
| Co-Target Name | Tyrosine protein kinase JAK1-Non receptor tyrosine protein kinase TYK2 (JAK1-TYK2) | Co-Target | ||||
| UniProt ID | JAK1_HUMAN-TYK2_HUMAN | |||||
| Gene Name | JAK1-TYK2 | |||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 15 nM | [1] | ||
| Co-Target Name | JAK1-JAK2-TYK2 complex (JAK1-JAK2-TYK2) | Co-Target | ||||
| UniProt ID | JAK1_HUMAN-JAK2_HUMAN-TYK2_HUMAN | |||||
| Gene Name | JAK1-JAK2-TYK2 | |||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 16 nM | [1] | ||
| Co-Target Name | Tyrosine protein kinase JAK1-Tyrosine protein kinase JAK3 complex (JAK1-JAK3) | Co-Target | ||||
| UniProt ID | JAK3_HUMAN-JAK1_HUMAN | |||||
| Gene Name | JAK1-JAK3 | |||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 67 nM | [1] | ||
| Co-Target Name | Tyrosine protein kinase JAK2-Non receptor tyrosine protein kinase TYK2 complex (JAK2-TYK2) | Co-Target | ||||
| UniProt ID | JAK2_HUMAN-TYK2_HUMAN | |||||
| Gene Name | JAK2-TYK2 | |||||
| Representative Drug(s) | Baricitinib | Drug Info | IC50 = 81.9 nM | [2] | ||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors. J Med Chem. 2016 Jan 28;59(2):733-49. | ||||
| REF 2 | Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. J Med Chem. 2014 Jun 26;57(12):5023-38. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.